Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. E.
Right arrow Articles by Chen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. E.
Right arrow Articles by Chen, J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2748-2756, 2004
© 2004 by the American Diabetes Association, Inc.

Regulation of Peroxisome Proliferator–Activated Receptor-{gamma} Activity by Mammalian Target of Rapamycin and Amino Acids in Adipogenesis

Jae Eun Kim, and Jie Chen

From the Department of Cell and Structural Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois

Adipocyte differentiation is a developmental process that is critical for metabolic homeostasis and nutrient signaling. The mammalian target of rapamycin (mTOR) mediates nutrient signaling to regulate cell growth, proliferation, and diverse cellular differentiation. It has been reported that rapamycin, the inhibitor of mTOR and an immunosuppressant, blocks adipocyte differentiation, but the mechanism underlying this phenomenon remains unknown. Here we show that mTOR plays a critical role in 3T3-L1 preadipocyte differentiation and that mTOR kinase activity is required for this process. Rapamycin specifically disrupted the positive transcriptional feedback loop between CCAAT/enhancer-binding protein-{alpha} and peroxisome proliferator–activated receptor-{gamma} (PPAR-{gamma}), two key transcription factors in adipogenesis, by directly targeting the transactivation activity of PPAR-{gamma}. In addition, we demonstrate for the first time that PPAR-{gamma} activity is dependent on amino acid sufficiency, revealing a molecular link between nutrient status and adipogenesis. The results of our further investigation have led us to propose a model in which the mTOR pathway and the phosphatidylinositol 3-kinase/Akt pathway act in parallel to regulate PPAR-{gamma} activation during adipogenesis by mediating nutrient availability and insulin signals, respectively. It is interesting that troglitazone (a thiazolidinedione drug) reversed the inhibitory effects of rapamycin and amino acid deprivation, implicating therapeutic values of thiazolidinedione drugs to counter certain side effects of rapamycin as an immunosuppressant.

Address correspondence and reprint requests to Jie Chen, Department of Cell and Structural Biology, University of Illinois at Urbana-Champaign, 601 S. Goodwin Ave., B107 Urbana, IL 61801. E-mail: jiechen{at}uiuc.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. C. Ruffolo, P. K. A. Forsell, X. Yuan, S. Desmarais, J. Himms-Hagen, W. Cromlish, K. K. Wong, and B. P. Kennedy
Basal Activation of p70S6K Results in Adipose-specific Insulin Resistance in Protein-tyrosine Phosphatase 1B / Mice
J. Biol. Chem., October 19, 2007; 282(42): 30423 - 30433.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Krebs, B. Brunmair, A. Brehm, M. Artwohl, J. Szendroedi, P. Nowotny, E. Roth, C. Furnsinn, M. Promintzer, C. Anderwald, et al.
The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man
Diabetes, June 1, 2007; 56(6): 1600 - 1607.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. L. Bennett, B. Hackanson, L. T. Smith, C. D. Morrison, J. C. Lang, D. E. Schuller, F. Weber, C. Eng, and C. Plass
Tumor Suppressor Activity of CCAAT/Enhancer Binding Protein {alpha} Is Epigenetically Down-regulated in Head and Neck Squamous Cell Carcinoma
Cancer Res., May 15, 2007; 67(10): 4657 - 4664.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Yoshiga, N. Sato, T. Torisu, H. Mori, R. Yoshida, S. Nakamura, G. Takaesu, T. Kobayashi, and A. Yoshimura
Adaptor Protein SH2-B Linking Receptor-Tyrosine Kinase and Akt Promotes Adipocyte Differentiation by Regulating Peroxisome Proliferator-Activated Receptor {gamma} Messenger Ribonucleic Acid Levels
Mol. Endocrinol., May 1, 2007; 21(5): 1120 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Jankiewicz, B. Groner, and S. Desrivieres
Mammalian Target of Rapamycin Regulates the Growth of Mammary Epithelial Cells through the Inhibitor of Deoxyribonucleic Acid Binding Id1 and Their Functional Differentiation through Id2
Mol. Endocrinol., October 1, 2006; 20(10): 2369 - 2381.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.